The Degree of CMV-Specific T Cell Response Is Related with Infection Complications in Heart Transplant Recipients

被引：0
|
作者：
Youn, J. [1 ]
Lee, J. [2 ]
Han, S. [1 ]
Kang, S. [3 ]
Shin, E. [2 ]
机构：
[1] Hallym Univ, Gyeonggido, South Korea
[2] Korea Adv Inst Sci & Technol, Daejeon, South Korea
[3] Yonsei Univ, Seoul, South Korea
来源：
JOURNAL OF HEART AND LUNG TRANSPLANTATION | 2017年 / 36卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
101
引用
收藏
页码：S47 / S48
页数：2
相关论文
共 50 条
  • [21] Kinetic of the CMV-specific T-cell immune response and CMV infection in CMV-seropositive kidney transplant recipients receiving rabbit anti-thymocyte globulin induction therapy: A pilot study
    Martin-Gandul, Cecilia
    Perez-Romero, Pilar
    Mena-Romo, Damian
    Molina-Ortega, Alejandro
    Gonzalez-Roncero, Francisco M.
    Suner, Marta
    Bernal, Gabriel
    Cordero, Elisa
    TRANSPLANT INFECTIOUS DISEASE, 2018, 20 (03)
  • [22] CMV-Specific T Cell Monitoring Offers Superior Risk Stratification of CMV-Seronegative Kidney Transplant Recipients of a CMV-Seropositive Donor
    Schachtner, Thomas
    Stein, Maik
    Reinke, Petra
    TRANSPLANTATION, 2017, 101 (10) : E315 - E325
  • [23] CMV-SPECIFIC IMMUNITY AND CMV COMPLICATIONS IN SEROPOSITIVE HCT RECIPIENTS DEPEND ON DONOR SEROSTATUS
    Ugarte-Torres, A.
    Liu, Y.
    Williamson, T.
    Hoegh-Petersen, M.
    Quinlan, D.
    Roa, L.
    Khan, F.
    Russell, J. A.
    Storek, J.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (02) : S175 - S175
  • [24] CMV viremia and development of CMV-specific cytotoxic t-cells (CMV-TC) in pediatric renal transplant recipients
    Pizzo, Helen
    Shin, Bongha
    Toyoda, Mieko
    Jordan, Stanley
    Puilyanda, Dechu
    PEDIATRIC TRANSPLANTATION, 2019, 23
  • [25] CMV-Specific Immunity and CMV Complications in Seropositive HCT Recipients Depend On Donor Serostatus
    Ugarte-Torres, Alejandra
    Liu, Yiping
    Williamson, Tyler
    Hoegh-Petersen, Mette
    Quinlan, Diana
    Roa, Lina
    Khan, Faisal
    Russell, James A.
    Storek, Jan
    BLOOD, 2009, 114 (22) : 886 - 886
  • [26] Is It Feasible to Use CMV-Specific T-Cell Adoptive Transfer as Treatment Against Infection in SOT Recipients?
    Garcia-Rios, Estefani
    Nuevalos, Marcos
    Mancebo, Francisco J.
    Perez-Romero, Pilar
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [27] Increased risk of late CMV infection and disease in allogeneic marrow transplant recipients after ganciclovir prophylaxis is due to a lack of CMV-specific T cell responses.
    Boeckh, M
    Riddell, SR
    Cunningham, T
    Myerson, D
    Flowers, M
    Bowden, RA
    BLOOD, 1996, 88 (10) : 1195 - 1195
  • [28] Striking Expansion and Persistence of T-bet+CD8+ CMV-Specific T Cells with Primary Infection in Lung Transplant Recipients
    Pipeling, M. R.
    Whitlock, A. B.
    Migueles, S. A.
    Connors, M.
    McDyer, J. F.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2009, 28 (02): : S253 - S253
  • [29] CMV-specific T-cell Response After Lung Transplantation
    Rossetti, V.
    Morlacchi, L.
    Lunghi, G.
    Briganti, D.
    Renteria, S. Uceda
    Tarsia, P.
    Damarco, F.
    Mendogni, P.
    Palleschi, A.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2018, 37 (04): : S176 - S177
  • [30] CMV INFECTION IN HEART-TRANSPLANT RECIPIENTS
    THOMPSON, KS
    PLAPP, FV
    LONG, ND
    HEENAN, TA
    TRANSFUSION, 1992, 32 (08) : S65 - S65
12345